Feng Zhou

5.9k citations
95 papers · 3.0k indexed · 1 hit paper · h-index 29

Feng Zhou

92 papers receiving 3.0k citations

Hit Papers

Unexpected Rapid Increase in the Burden of NAFLD in China...4182019202620212023100200300400

Peers

Feng Zhou
Comparison fields: 5 of 121
  • Cancer Research 691
  • Hepatology 181
  • Epidemiology 739
  • Molecular Biology 1.5k
  • Orthopedics and Sports Medicine 164
Replace Xiaoyu Song with:
Xiaoyu Song China
Ping Wen China
Giovanni Malerba Italy
Yongde Peng China
Lisa Choy United States
Hyun Sub Cheong South Korea
Min Zhu China
Lan‐Juan Zhao China
Dilip K. Deb United States
Tomoko Sonoda Japan
Feng Zhou relative to Xiaoyu Song China Xiaoyu Song's profile →
Citations per field
00.5×3.8×
Xiaoyu Song · 1×
Citations per year

Countries citing papers authored by Feng Zhou

Since Specialization
Citations

This map shows the geographic impact of Feng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Zhou more than expected).

Fields of papers citing papers by Feng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Zhou. The network helps show where Feng Zhou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Feng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feng Zhou Line = papers co-authored together Feng Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20249
3 20242
4 20241
5 20232
6 20236
7 202171
8 202112
9 2019129
10 20192
11 201939
12 20199
13 20182
14 201729
15 201715
16 2014182
17 20137
18 201272
19 201131
20 200726

About Feng Zhou

Feng Zhou is a scholar working on Cancer Research, Immunology, Genetics, Hepatology and Molecular Biology, having authored 95 papers that have together received 3.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (13 papers), Immune Cell Function and Interaction (8 papers), MicroRNA in disease regulation (7 papers), Microscopic Colitis (7 papers), Cancer-related molecular mechanisms research (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Immune Response and Inflammation (7 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Cancer Research (691 citations), Hepatology (181 citations), Epidemiology (739 citations), Molecular Biology (1.5k citations) and Orthopedics and Sports Medicine (164 citations). Feng Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hongliang Li, Jingjing Cai, Zhi‐Gang She, Xiao‐Jing Zhang, Jinliang Xing, Jianghua Zhou, Yan‐Xiao Ji, Peng Zhang, Wenxin Wang and Lihua Zhu. Their work appears in journals such as Cell Death and Differentiation, PLoS ONE, Journal of Gastroenterology and Hepatology, Water and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026